Johnson & Johnson urged to improve access to tuberculosis drug

Global health aid agency Unitaid has written to Johnson & Johnson CEO Joaquin Duato, urging him to take “immediate action” to expand access to the company’s TB drug bedaquiline, which is protected by patents that hinder generic alternatives.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM